Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ
O Solís, J Addae, R Sweeting, I Meszoely… - Breast Cancer Research …, 2024 - Springer
Purpose Recent studies have established the safety and efficacy of Superparamagnetic Iron
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Avoiding unnecessary sentinel lymph node biopsy with the use of superparamagnetic iron oxide mapping agents (Magtrace®) in breast surgery
RBJ Cui, S Hawes, F Azimi, B Chan… - ANZ Journal of …, 2024 - Wiley Online Library
Background Superparamagnetic iron oxide (SPIO)(Magtrace®) is a non‐radioactive liquid
tracer that can stay in the sentinel lymph nodes for 30 days. Injection of SPIO at time of …
tracer that can stay in the sentinel lymph nodes for 30 days. Injection of SPIO at time of …
Clinical Longevity of Preoperative Injection of Superparamagnetic Iron Oxide Nanoparticles for Delayed Sentinel Lymph Node Biopsy
G Muanamputu, BK Sparkman… - The American …, 2024 - journals.sagepub.com
Diagnosis of ductal carcinoma in situ (DCIS) represents about 25% of newly diagnosed
breast cancers. There is debate about the benefit of sentinel lymph node biopsy (SLNB) for …
breast cancers. There is debate about the benefit of sentinel lymph node biopsy (SLNB) for …
Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience
JK Addae, RS Sweeting, IM Meszoely… - Breast Cancer Research …, 2024 - Springer
Purpose Unnecessary axillary surgery can potentially be avoided in patients with DCIS
undergoing mastectomy. Current guidelines recommend upfront sentinel lymph node biopsy …
undergoing mastectomy. Current guidelines recommend upfront sentinel lymph node biopsy …
Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal …
A Karakatsanis, AF Hersi, L Pistiolis… - Journal of British …, 2019 - academic.oup.com
Background One-fifth of patients with a preoperative diagnosis of ductal carcinoma in situ
(DCIS) have invasive breast cancer (IBC) on definitive histology. Sentinel lymph node …
(DCIS) have invasive breast cancer (IBC) on definitive histology. Sentinel lymph node …
Magnetic lymphatic tracing for omission of sentinel lymph node biopsies in mastectomy patients: a community cancer center experience
M Samaha, A Fellner, K Raque, A Kuritzky… - Breast Cancer Research …, 2024 - Springer
Background Patients with ductal carcinoma in situ (DCIS) and patients undergoing risk
reduction mastectomy may undergo sentinel lymph node biopsy (SLNB) at the time of …
reduction mastectomy may undergo sentinel lymph node biopsy (SLNB) at the time of …
Delayed sentinel lymph node dissection in patients with a preoperative diagnosis of ductal cancer in situ by preoperative injection with superparamagnetic iron oxide …
A Karakatsanis, S Eriksson, L Pistiolis… - Annals of Surgical …, 2023 - Springer
Background Difficulty in preoperatively assessing the risk for occult invasion or surgery that
precludes future accurate axillary mapping in patients with ductal cancer in situ (DCIS) …
precludes future accurate axillary mapping in patients with ductal cancer in situ (DCIS) …
Skin Staining After Injection of Superparamagnetic Iron Oxide for Sentinel Lymph Node Dissection: A Retrospective Study of Two Protocols for Injection and Long …
MP Mathey, C Simonson… - European Journal of …, 2024 - search.ebscohost.com
Objective: Sentinel lymph node (SLN) dissection is a highly accurate surgical procedure
allowing detection of lymph node invasion in patients with clinically negative axilla in early …
allowing detection of lymph node invasion in patients with clinically negative axilla in early …
Sentinel lymph node biopsy in early breast cancer: magnetic tracer as the only localizing agent
V Man, TT Wong, M Co, D Suen, A Kwong - World journal of surgery, 2019 - Springer
Background The combined use of radioisotope and blue dye is the gold standard in sentinel
lymph node (SLN) localization in early breast cancer. Superparamagnetic iron oxide (SPIO) …
lymph node (SLN) localization in early breast cancer. Superparamagnetic iron oxide (SPIO) …
Increased detection of sentinel nodes in breast cancer patients with the use of superparamagnetic iron oxide tracer.
IT Rubio, S Diaz-Botero, AJ Esgueva… - 2014 - ascopubs.org
100 Background: The use of superparamagnetic iron oxide (SPIO) tracer for sentinel node
biopsy (SLN) has shown non inferiority compared with the radioisotope technique in early …
biopsy (SLN) has shown non inferiority compared with the radioisotope technique in early …